Ingenia Therapeutics

950260 · KOSDAQ · Industrials · SMALL CAP

Material management matter relevant to investment decisions

(Material management matter relevant to investment decisions)· FILED 2026-09-28· RCEPT 20260928900646

About this filing

A material business event the company considers relevant to investors that does not fit a standard form; the filing describes it.

Why companies file it: Companies must disclose information that could affect investment decisions.

A full English translation of this filing is not available yet. The original (in Korean) is linked below.

Filed2026-09-28, Material management matter relevant to investment decisions
SourceDART rcept 20260928900646 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-09-28 (KST). · FX: 1 USD ≈ ₩1,343 (rate of 2026-10-05).